Vaccine Duo Gives Pancreatic Cancer Patients Two Months Extra

Dr. Le of the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center has announced that a phase II trial has shown that serial administration of two cancer vaccines has produced a positive improvement in the survival times for sufferers of metastatic pancreatic cancer. The trail saw patients receive the GVAX Pancreas vaccine followed by CRS-207. The interim results show that …